Valuation: 10x Genomics, Inc.

Market Cap 5.42B 4.76B 4.41B 4.05B 7.67B 519B 7.82B 52.52B 20.6B 255B 20.37B 19.93B 881B P/E 2026 *
-52.4x
P/E 2027 * -59.6x
Enterprise Value 4.94B 4.33B 4.01B 3.69B 6.98B 473B 7.12B 47.83B 18.76B 232B 18.55B 18.15B 802B EV / Sales 2026 *
8.05x
EV / Sales 2027 * 7.32x
Free-Float
90.53%
Yield 2026 *
-
Yield 2027 * -
1 day-0.78%
1 week+5.92%
Current month+10.51%
1 month+31.50%
3 months+79.69%
6 months+106.48%
Current year+159.78%
1 week 35.12
Extreme 35.12
43.98
1 month 29.66
Extreme 29.6605
43.98
Current year 15.9
Extreme 15.9
43.98
1 year 11.16
Extreme 11.16
43.98
3 years 6.78
Extreme 6.78
63.57
5 years 6.78
Extreme 6.78
191.15
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 2012-07-01
President 51 2012-09-30
Director of Finance/CFO 51 2024-08-11
Director TitleAgeSince
Director/Board Member 51 2012-07-01
Director/Board Member 49 2012-07-01
Chairman 68 2013-07-31
Date Insider Type Main position Quantity % Market Cap.
06-21Sell

Founder

-30,000 0.0257%
06-15Sell

Director

-5,723 0.0049%
06-03Free

Director

8,829 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%+5.92%+239.78%-26.47% 5.42B
-0.92%-5.92%+219.13%+308.93% 21.22B
+1.50%+1.87%-40.76%-24.56% 9.41B
-0.27%+2.70%+27.14%+25.09% 6.88B
+1.47%-0.18%-19.88%-26.73% 5.05B
-0.18%-4.60%-38.71% - 4.8B
+0.96%-0.97%-23.24%-26.37% 4.17B
-5.85%-16.68%+51.09%+60.79% 3.64B
+1.36%+0.58%-17.57%-42.60% 2.59B
-3.87%-2.83%-36.10%+189.25% 1.61B
Average -0.68%-0.85%+36.09%+48.59% 6.48B
Weighted average by Cap. -0.41%-1.34%+84.15%+108.75%

Financials

2026 *2027 *
Net sales 614M 538M 499M 459M 868M 58.76B 885M 5.94B 2.33B 28.86B 2.31B 2.26B 99.66B 670M 588M 544M 501M 947M 64.11B 965M 6.49B 2.54B 31.48B 2.52B 2.46B 109B
Net income -105M -92.03M -85.24M -78.43M -148M -10.04B -151M -1.02B -398M -4.93B -394M -385M -17.03B -93.32M -81.85M -75.81M -69.75M -132M -8.93B -134M -903M -354M -4.39B -350M -343M -15.15B
Net Debt -485M -425M -394M -362M -685M -46.38B -698M -4.69B -1.84B -22.78B -1.82B -1.78B -78.66B -524M -460M -426M -392M -741M -50.17B -756M -5.08B -1.99B -24.64B -1.97B -1.93B -85.09B
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
Employees
1,178
Date Price Change Volume
26-07-13 US$42.27 -1.08% 978,413
26-07-10 US$42.73 -0.86% 2,832,915
26-07-09 US$43.10 +15.03% 2,997,474
26-07-08 US$37.47 -0.95% 3,100,234
26-07-07 US$37.83 -5.43% 2,432,456
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
42.73USD
Average target price
32.08USD
Spread / Average Target
-24.93%

Quarterly revenue - Rate of surprise